Literature DB >> 23073905

Geranylgeranyltransferase I promotes human glioma cell growth through Rac1 membrane association and activation.

Xiuping Zhou1, Jinming Qian, Lei Hua, Qiong Shi, Zhi Liu, Yinfu Xu, Ben Sang, Jianbing Mo, Rutong Yu.   

Abstract

Geranylgeranyltransferase I (GGTase-I) is responsible for the posttranslational lipidation of several signaling proteins such as RhoA, Rac1, and Cdc42, which contribute to tumor development and metastasis. However, the role of GGTase-I in the progression of human glioma is largely unknown. Here, we provide the evidence that Rac1 mediates the effects of GGTase-I on the proliferation and apoptosis in human glioma cells. We found that GGTase-I was abundantly expressed in human primary glioma tissues. Inhibition or downregulation of GGTase-I markedly decreased the proliferation of glioma cells and induced their apoptosis, while overexpression of GGTase-I promoted cell growth in vitro. Inactivation of GGTase-I eliminated geranylgeranylation of RhoA and Rac1, prevented them from targeting to the plasma membrane, and inhibited Rac1 activity. Furthermore, overexpressing wild type or constitutively active Rac1 stimulated glioma cell growth, similar to the effect of GGTase-I overexpression. Importantly, overexpressing dominant-negative Rac1 or Rac1 with the prenylation site deleted or mutated abrogated GGTase-I-induced proliferation in glioma cells. These results confirm the view that geranylgeranylation is essential to the activity and localization of Rho family proteins and suggest that Rac1 is required for GGTase-I-mediated glioma growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073905     DOI: 10.1007/s12031-012-9905-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  54 in total

1.  Rho GTPases: deciphering the evolutionary history of a complex protein family.

Authors:  Marek Eliáš; Vladimír Klimeš
Journal:  Methods Mol Biol       Date:  2012

2.  Inactivating GGTase-I reduces disease phenotypes in a mouse model of K-RAS-induced myeloproliferative disease.

Authors:  A-K M Sjogren; K M E Andersson; O Khan; F J Olofsson; C Karlsson; M O Bergo
Journal:  Leukemia       Date:  2010-10-26       Impact factor: 11.528

Review 3.  Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I.

Authors:  Kimberly T Lane; Lorena S Beese
Journal:  J Lipid Res       Date:  2006-02-13       Impact factor: 5.922

4.  Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.

Authors:  Akira Fukuda; Atsuhiko Hikita; Hidetoshi Wakeyama; Toru Akiyama; Hiromi Oda; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Res       Date:  2005-08-22       Impact factor: 6.741

5.  Inhibition of GGTase-I and FTase disrupts cytoskeletal organization of human PC-3 prostate cancer cells.

Authors:  Sanna S Virtanen; Jouko Sandholm; Gennady Yegutkin; H Kalervo Väänänen; Pirkko L Härkönen
Journal:  Cell Biol Int       Date:  2010-08       Impact factor: 3.612

6.  Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.

Authors:  D D Chi; R E Merchant; R Rand; A J Conrad; D Garrison; R Turner; D L Morton; D S Hoon
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

7.  In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion.

Authors:  Eishu Hirata; Hiroko Yukinaga; Yuji Kamioka; Yoshiki Arakawa; Susumu Miyamoto; Takaharu Okada; Erik Sahai; Michiyuki Matsuda
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

Review 8.  Protein prenylation: molecular mechanisms and functional consequences.

Authors:  F L Zhang; P J Casey
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 9.  Role of Rho GTPases and their regulators in cancer progression.

Authors:  Rajamani Rathinam; Allison Berrier; Suresh K Alahari
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

Review 10.  Protein prenyltransferases.

Authors:  Sebastian Maurer-Stroh; Stefan Washietl; Frank Eisenhaber
Journal:  Genome Biol       Date:  2003-04-01       Impact factor: 13.583

View more
  8 in total

1.  FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.

Authors:  Lei Hua; Ming Zhu; Xu Song; Jun Wang; Zhen Fang; Chunting Zhang; Qiong Shi; Wenjian Zhan; Lei Wang; Qingming Meng; Xiuping Zhou; Rutong Yu
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

2.  Involvement of RalB in the effect of geranylgeranyltransferase I on glioma cell migration and invasion.

Authors:  X Song; L Hua; Y Xu; Z Fang; Y Wang; J Gao; Q Shi; X Zhou; R Yu
Journal:  Clin Transl Oncol       Date:  2015-01-09       Impact factor: 3.405

Review 3.  The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain.

Authors:  Shangfeng Gao; Rutong Yu; Xiuping Zhou
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

4.  Inference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of Cancer.

Authors:  Kim Clarke; Thomas Daubon; Nil Turan; Fabienne Soulet; Maihafizah Mohd Zahari; Katie R Ryan; Sarah Durant; Shan He; John Herbert; John Ankers; John K Heath; Rolf Bjerkvig; Roy Bicknell; Neil A Hotchin; Andreas Bikfalvi; Francesco Falciani
Journal:  PLoS Genet       Date:  2015-07-01       Impact factor: 5.917

5.  Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation.

Authors:  Sherry S Agabiti; Jin Li; Andrew J Wiemer
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

Review 6.  Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma.

Authors:  Fahim Ahmad; Qian Sun; Deven Patel; Jayne M Stommel
Journal:  Cancers (Basel)       Date:  2019-01-26       Impact factor: 6.639

7.  CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica.

Authors:  Lukmanee Tradtrantip; Tianjiao Duan; Michael R Yeaman; Alan S Verkman
Journal:  J Neuroinflammation       Date:  2019-03-09       Impact factor: 8.322

Review 8.  Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.

Authors:  Shannon Patricia Fortin Ensign; Ian T Mathews; Marc H Symons; Michael E Berens; Nhan L Tran
Journal:  Front Oncol       Date:  2013-10-04       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.